Characterization of the severe phenotype of pyruvate kinase deficiency-Reference-Cited by-同舟云学术

Characterization of the severe phenotype of pyruvate kinase deficiency

Published:2020-08-06 Issue:10 Volume:95 Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Al‐Samkari Hanny¹^ORCID,Beers Eduard J.²,Morton D. Holmes³⁴,Barcellini Wilma⁵,Eber Stefan W.⁶,Glader Bertil⁷,Yaish Hassan M.⁸,Chonat Satheesh⁹^ORCID,Kuo Kevin H. M.¹⁰,Kollmar Nina¹¹,Despotovic Jenny M.¹²,Pospíšilová Dagmar¹³,Knoll Christine M.¹⁴,Kwiatkowski Janet L.¹⁵^ORCID,Pastore Yves D.¹⁶,Thompson Alexis A.¹⁷,Wlodarski Marcin W.¹⁸¹⁹,Ravindranath Yaddanapudi²⁰,Rothman Jennifer A.²¹,Wang Heng²²,Holzhauer Susanne²³,Breakey Vicky R.²⁴,Verhovsek Madeleine M.²⁴^ORCID,Kunz Joachim²⁵,Sheth Sujit²⁶^ORCID,Sharma Mukta²⁷,Rose Melissa J.²⁸,Bradeen Heather A.²⁹,McNaull Melissa N.³⁰,Addonizio Kathryn³¹^ORCID,Al‐Sayegh Hasan³¹,London Wendy B.³¹,Grace Rachael F.³¹^ORCID

Affiliation:

1. Division of Hematology Massachusetts General Hospital, Harvard Medical School Boston Massachusetts

2. Universitair Medisch Centrum Utrecht Utrecht The Netherlands

3. Central Pennsylvania Clinic for Special Children & Adults Belleville Pennsylvania

4. Lancaster General Hospital Lancaster Pennsylvania

5. Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy

6. Schwerpunktpraxis für Pädiatrische Hämatologie‐Onkologie and Children's Hospital Technical University Munich Germany

7. Lucile Packard Children's Hospital Stanford University Palo Alto California

8. Primary Children's Hospital University of Utah Salt Lake City Utah

9. Emory University School of Medicine, Aflac Cancer and Blood Disorders Center Children's Healthcare of Atlanta Atlanta Georgia

10. University of Toronto, University Health Network Toronto Ontario Canada

11. Klinikum Kassel GmbH Kassel Germany

12. Texas Children's Hematology Center Baylor College of Medicine Houston Texas

13. Fakultni nemocnice Olomouc Olomouc Czech Republic

14. Phoenix Children's Hospital Phoenix Arizona

15. Children's Hospital of Philadelphia and Perelman School of Medicine of the University of Pennsylvania Philadelphia Pennsylvania

16. CHU Sainte‐Justine Montreal Canada

17. Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois

18. St. Jude Children's Research Hospital Memphis Tennessee

19. University of Freiburg Freiburg Germany

20. Children's Hospital of Michigan Wayne State University School of Medicine Detroit Michigan

21. Duke University Medical Center Durham North Carolina

22. DDC Clinic for Special Needs Children Middlefield Ohio

23. Charité University Medicine Berlin Germany

24. McMaster University Hamilton Ontario Canada

25. Zentrum für Kinder‐und Jugendmedizin Heidelberg Germany

26. Weill Cornell Medical College New York Presbyterian Hospital New York New York

27. Children's Mercy University of Missouri Kansas City School of Medicine Kansas City Missouri

28. Nationwide Children's Hospital The Ohio State University College of Medicine Columbus Ohio

29. The University of Vermont Children's Hospital Burlington Vermont

30. University of Mississippi Medical Center Jackson Mississippi

31. Dana‐Farber Boston Children's Cancer and Blood Disorder Center Harvard Medical School Boston Massachusetts

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25926

Reference8 articles.

1. Molecular and clinical heterogeneity in pyruvate kinase deficiency in India

2. Pyruvate kinase deficiency in France: a 3-year study reveals 27 new mutations

3. Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study

4. The variable manifestations of disease in pyruvate kinase deficiency and their management

5. Red Cell Pyruvate Kinase Deficiency

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and management of pyruvate kinase deficiency: international expert guidelines;The Lancet Haematology;2024-02

2. Updates and advances in pyruvate kinase deficiency;Trends in Molecular Medicine;2023-05

3. The Pyruvate Kinase Deficiency Global Longitudinal (Peak) Registry: rationale and study design;BMJ Open;2023-03

4. An evaluation of mitapivat for the treatment of hemolytic anemia in adults with pyruvate kinase deficiency;Expert Review of Hematology;2022-09-22

5. Pyruvate Kinase Deficiency: Current Challenges and Future Prospects;Journal of Blood Medicine;2022-09